Skip to main content
Fig. 13 | Cancer Nanotechnology

Fig. 13

From: Delivery of melittin-loaded niosomes for breast cancer treatment: an in vitro and in vivo evaluation of anti-cancer effect

Fig. 13

Microscopic views of mammary gland adenocarcinoma. H&E staining of cancer control (original magnification, ×400) (a); H&E staining of healthy control (original magnification, ×400) (b); H&E staining of melittin 3 mg/kg (original magnification, ×400) (c); H&E staining of melittin 6 mg/kg (original magnification, ×400) (d); H&E staining of melittin-loaded niosome 1.5 mg/kg (original magnification ×400) (e); H&E staining of melittin-loaded niosome 3 mg/kg (original magnification, ×400) (f); H&E staining of empty niosome 6 mg/kg (original magnification, ×400) (g). (N: necrosis/arrowhead: polymorphism/arrow: cancer tissue, and cell mitosis)

Back to article page